Alexandre Bonet

457 total citations
15 papers, 378 citations indexed

About

Alexandre Bonet is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Alexandre Bonet has authored 15 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Alexandre Bonet's work include Cholinesterase and Neurodegenerative Diseases (8 papers), Computational Drug Discovery Methods (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Alexandre Bonet is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (8 papers), Computational Drug Discovery Methods (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Alexandre Bonet collaborates with scholars based in France, Spain and Poland. Alexandre Bonet's co-authors include Hélène Martin, Lysiane Richert, Bruno Heyd, Catherine Abadie, Dumrongsak Pekthong, Lhassane Ismaïli, Alain Berthelot, Nadège Blanchard, José Marco‐Contelles and Georges Mantion and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Alexandre Bonet

15 papers receiving 365 citations

Peers

Alexandre Bonet

PHARM

CAM

Hongtao Du China

Amira Mira Egypt

Shitang Ma China

Hong Ji China

Laurie P. Volak United States

Olivia R. Dale United States

Matthew Iyobhebhe Nigeria

Lele Ding China

Sushant Shengule India

Hongtao Du China

Alexandre Bonet

116 ×1.0

PHARM

57 ×0.5

PHARM

104 ×1.0

CAM

66 ×0.7

159 ×1.9

Citations per year, relative to Alexandre Bonet Alexandre Bonet (= 1×) peers Hongtao Du

Countries citing papers authored by Alexandre Bonet

Since Specialization

Citations

This map shows the geographic impact of Alexandre Bonet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Bonet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Bonet more than expected).

Fields of papers citing papers by Alexandre Bonet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Bonet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Bonet. The network helps show where Alexandre Bonet may publish in the future.

Co-authorship network of co-authors of Alexandre Bonet

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Bonet. A scholar is included among the top collaborators of Alexandre Bonet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Bonet. Alexandre Bonet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Luzet, Vincent, Alexandre Bonet, Dominique Harakat, et al.. (2024). Synthesis and evaluation of lipoic acid – donepezil hybrids for Alzheimer’s disease using a straightforward strategy. Bioorganic & Medicinal Chemistry Letters. 112. 129938–129938. 2 indexed citations

Martin, Hélène, Ignacio Moraleda, Alexandre Bonet, et al.. (2020). Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives. International Journal of Molecular Sciences. 21(20). 7652–7652. 13 indexed citations

Martin, Hélène, Alexandre Bonet, Artur Wnorowski, et al.. (2020). Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels. Molecules. 25(6). 1329–1329. 14 indexed citations

Martin, Hélène, Alexandre Bonet, Mourad Chioua, et al.. (2017). Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinetriones as Promising Agents for Alzheimer'S Disease Therapy. Future Medicinal Chemistry. 9(8). 715–721. 10 indexed citations

Boulebd, Houssem, Lhassane Ismaïli, Hélène Martin, et al.. (2017). New (Benz)Imidazolopyridino Tacrines as Nonhepatotoxic, Cholinesterase Inhibitors for Alzheimer Disease. Future Medicinal Chemistry. 9(8). 723–729. 27 indexed citations

Boulebd, Houssem, Lhassane Ismaïli, Manuela Bartolini, et al.. (2016). Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy. Molecules. 21(4). 400–400. 19 indexed citations

Luzet, Vincent, Justyna Godyń, Dawid Panek, et al.. (2016). Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy. European Journal of Medicinal Chemistry. 126. 576–589. 34 indexed citations

Bautista‐Aguilera, Óscar M., Mohamed Benchekroun, Hélène Martin, et al.. (2016). Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease. Molecules. 21(5). 634–634. 26 indexed citations

Richert, Lysiane, Catherine Abadie, Alexandre Bonet, et al.. (2009). Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers – A European Centre for Validation of Alternative Methods (ECVAM) – Funded pre-validation study. Toxicology in Vitro. 24(1). 335–345. 17 indexed citations

10.

Richert, Lysiane, Gregor Tuschl, Catherine Viollon‐Abadie, et al.. (2008). Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro. Drug Metabolism and Disposition. 36(4). 702–714. 23 indexed citations

11.

Pekthong, Dumrongsak, Nadège Blanchard, Catherine Abadie, et al.. (2008). Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures. Chemico-Biological Interactions. 179(2-3). 247–255. 63 indexed citations

12.

Martin, Hélène, B. Uring‐Lambert, Alexandre Bonet, et al.. (2008). Effects of long-term dietary intake of magnesium on oxidative stress, apoptosis and ageing in rat liver.. PubMed. 21(2). 124–30. 34 indexed citations

13.

Girard, C., Alexandre Bonet, Catherine Viollon‐Abadie, et al.. (2007). Effect of Chrysin and Natural Coumarins on UGT1A1 and 1A6 Activities in Rat and Human Hepatocytes in Primary Culture. Planta Medica. 73(8). 742–747. 8 indexed citations

14.

Pekthong, Dumrongsak, Hélène Martin, Catherine Abadie, et al.. (2007). Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide. Journal of Ethnopharmacology. 115(3). 432–440. 59 indexed citations

15.

Binda, Delphine, Alexandre Bonet, Mireille Thomassin, et al.. (2003). Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of l-NAME. Toxicology in Vitro. 17(1). 59–67. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact